Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Tonix Pharmaceuticals Holding Corp (TNXP)

NASDAQ
Currency in USD
Disclaimer
0.1685
+0.0085(+5.31%)
Closed
After Hours
0.1669-0.0016(-0.9496%)

TNXP Comments

ExodusPoint Capital Management, LP bought 595,459 shares (update 2021-05-17)!!!!Vanguard Group Inc has 14,678,162 Mio. shares!!! (update 2021-05-14)
starting feel like someone poured sand on the skids.
so gaming only.
why is strong sell why is the reason
why is strong sell why is the reason
Tonix Pharmaceuticals Enters into Exclusive Worldwide Licensing Agreement with OyaGen to Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, for the Treatment of COVID-19
lol, what happen?
https://www.globenewswire.com/news-release/2021/04/19/2212234/28908/en/Tonix-Pharmaceuticals-Enters-into-Exclusive-Worldwide-Licensing-Agreement-with-OyaGen-to-Develop-Antiviral-SARS-CoV-2-Inhibitor-TNX-3500-for-the-Treatment-of-COVID-19.html
Common sense would tell me articles and attention like this would gain TNXP a lot of speculative interest. Especially with the gambling atmosphere on Reddit. Common sense has never really served me well in the market though. Feeling for the bottom with dry powder in hand.Motley Fool article (Apr 15) https://www.fool.com/investing/2021/04/15/2-best-reddit-healthcare-stocks-to-buy-now/ 
next week yuuge!!
Why?
apparently you know Jack doodlie squat about this stock. If by Friday this isn't up YouTube, how about never posting on this stock again. so sick of factless pumpers.
"yuuuge" , not YouTube.
Robinhood Investors Are Buying Tonix Pharmaceuticals Stock. Should You?There are two main reasons this small-cap biotech stock has gained a lot of attention. Keith Speights(TMFFishBiz)Apr 8, 2021 at 6:01AMYou've probably heard of most of the 100 most popular stocks on Robinhood. Many of them are household names. But there are also a handful of stocks that are widely held by investors on the trading platform that won't be familiar to most investors.Tonix Pharmaceuticals (NASDAQ:TNXP) stands out as a good example of these under-the-radar stocks. With the small biotech recently making it onto the most popular list, Robinhood investors are clearly buying the company's stock. But should you?
Find the article at Motley Fool
higt risk and high reward buy the dip and keep it for 3rd and 4th quartal of the year for x10 potential and long investment )))
I'm an owner...based on what info are you making your prediction from? Sure wish people would post useful info here and stop with the empty pumping.
on minimum successfull end of fibro and filing on FDA for it, 6 billion market, so all other medicaments are not good at the market in this moment, covid vaccine results and other results and move on to the 3rd part of trials, see the pipeline, think about the future. Of course there are a lot 'if" it works, but you need the risk and even if only fibro works its enough for the start of revenue. I never pump any stock i just buy so much i can now and do not care even if it will be longer in my portfolio i believe this company will reach moderna cap in the future, but for short period 10-12 is possibe on fibro results and FDA, if covid works and this is the only acctive vaccine this is going to fly over 100 easy, of course they would also dilute and so on, but whatever it will be more as 1 usd now, so the chance of "if" is higher for reward as the chance to loose a lot here. Only my opinion.
strong Buy!!
A Form 4 filing filed with the SEC on Thursday, March 25 showed that Lederman Seth bought 16,733 shares of Tonix Pharmaceuticals Inc (NASDAQ:TNXP) at an average price of $1.32. The transaction moved the executive's stake in Tonix Pharmaceuticals Inc. to 135,000 shares.
Insider Buys Tonix Pharmaceuticals StockBenzinga InsightsThu, March 25, 2021, 8:57 AM·TNXPA Form 4 filing filed with the SEC on Thursday, March 25 showed that Lederman Seth bought 16,733 shares of Tonix Pharmaceuticals Inc (NASDAQ:TNXP) at an average price of $1.32. The transaction moved the executive's stake in Tonix Pharmaceuticals Inc. to 135,000 shares. Tonix Pharmaceuticals was trading 2.4% lower from the previous closing price.Added to my position this morning.
Insider Buys Tonix Pharmaceuticals StockBenzinga InsightsThu, March 25, 2021, 8:57 AMTNXPA Form 4 filing filed with the SEC on Thursday, March 25 showed that Lederman Seth bought 16,733 shares of Tonix Pharmaceuticals Inc (NASDAQ:TNXP) at an average price of $1.32. The transaction moved the executive's stake in Tonix Pharmaceuticals Inc. to 135,000 shares. Tonix Pharmaceuticals was trading 2.4% lower from the previous closing price.
🚀🚀🚀🚀🚀
now White House covid-19 response team Briefing!!
tnxp covid-19 vaccine development is for the near future !!
I buy 10.000 more shers today!good luck !!
woow!!boom
yeah not the smartest guy in the room. Mid to end of Feburary he was saying this would jump to $10 that week.
not 10$!!TNXP WILL BE AT 100$ SOON THIS YEAR!!THIS is not for you
10 maybe, not 100 jajaj
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-results-pre-183000418.html
https://www.reddit.com/r/TNXP/comments/ly8s0p/tnxp_recently_advertising_engineering_job_roles/
Maybe Good news http://trnews.fnguide.com/Home/OriginalArticle?id=20210319:nL4N2LH2RB
still holding
MP, CLVS, SOS y TNXP entre los ganadores previos al mercado https://seekingalpha.com/news/3674377-mp-clvs-sos-and-tnxp-among-premarket-gainers?utm_source=investing.com&utm_medium=referral
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.